ClinicalTrials.Veeva

Menu

Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity

K

Kasr El Aini Hospital

Status

Completed

Conditions

Lupus Glomerulonephritis
Systemic Lupus Erthematosus
Lupus Flare

Treatments

Diagnostic Test: colour doppler of the renal artery and measurement of resistive index

Study type

Interventional

Funder types

Other

Identifiers

NCT06757725
MS-632-2022 (Other Identifier)

Details and patient eligibility

About

The study explores the role of the colour Doppler scanning of the renal arteries and its relation to the degree of disease affection in lupus nephritis

Full description

we have recruited patients into 3 groups The first group is patients with lupus nephritis The second groups is patients with systemic lupus erythromatosus without nephritis The third groups is normal healthy controls we explored the association of colour Doppler and the renal resistive index with the degree of the renal affection in lupus nephritis

Enrollment

75 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. Systemic lupus erythematosus. 2. Lupus nephritis. 3. Adults >18 years old.

Exclusion criteria

    1. End Stage Renal Disease. 2. Diabetes Mellitus. 3. Heart failure. 4. Hepatic diseases. 5. Obstructive nephropathy. 6. Renal artery stenosis or occlusion.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 3 patient groups

Patients with lupus nephritis
Active Comparator group
Description:
Theses are 25 patients diagnosed with lupus nephritis
Treatment:
Diagnostic Test: colour doppler of the renal artery and measurement of resistive index
Lupus without nephritis
Active Comparator group
Description:
Theses are 25 patients diagnosed with lupus without evidence of nephritis
Treatment:
Diagnostic Test: colour doppler of the renal artery and measurement of resistive index
Healthy control
No Intervention group
Description:
Patients who are healthy volunteers with no evidence of nephritis or systemic lupus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems